EP1003521A4 - METHODS OF POTENTIALIZING INTRAVENOUS PHOSPHATE ESTRAMUSTINE - Google Patents

METHODS OF POTENTIALIZING INTRAVENOUS PHOSPHATE ESTRAMUSTINE

Info

Publication number
EP1003521A4
EP1003521A4 EP99914884A EP99914884A EP1003521A4 EP 1003521 A4 EP1003521 A4 EP 1003521A4 EP 99914884 A EP99914884 A EP 99914884A EP 99914884 A EP99914884 A EP 99914884A EP 1003521 A4 EP1003521 A4 EP 1003521A4
Authority
EP
European Patent Office
Prior art keywords
potentiate
methods
estramustine phosphate
intravenous estramustine
intravenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99914884A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1003521A1 (en
Inventor
Michael S Kopreski
Beryl Asp
Bo Fredholm
Per-Olv Gunnarsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of EP1003521A1 publication Critical patent/EP1003521A1/en
Publication of EP1003521A4 publication Critical patent/EP1003521A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP99914884A 1998-03-27 1999-03-26 METHODS OF POTENTIALIZING INTRAVENOUS PHOSPHATE ESTRAMUSTINE Withdrawn EP1003521A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7954298P 1998-03-27 1998-03-27
US79542P 1998-03-27
PCT/US1999/004275 WO1999049869A1 (en) 1998-03-27 1999-03-26 Methods to potentiate intravenous estramustine phosphate

Publications (2)

Publication Number Publication Date
EP1003521A1 EP1003521A1 (en) 2000-05-31
EP1003521A4 true EP1003521A4 (en) 2003-07-23

Family

ID=22151209

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99914884A Withdrawn EP1003521A4 (en) 1998-03-27 1999-03-26 METHODS OF POTENTIALIZING INTRAVENOUS PHOSPHATE ESTRAMUSTINE

Country Status (16)

Country Link
EP (1) EP1003521A4 (ja)
JP (1) JP2001508810A (ja)
KR (1) KR20010021656A (ja)
CN (2) CN1273530A (ja)
AU (1) AU750010B2 (ja)
BR (1) BR9906425A (ja)
CA (1) CA2295049A1 (ja)
EA (1) EA004647B1 (ja)
HU (1) HUP0200547A3 (ja)
ID (1) ID24504A (ja)
IL (1) IL133612A0 (ja)
NO (1) NO20002343L (ja)
NZ (1) NZ501987A (ja)
PL (1) PL342969A1 (ja)
WO (1) WO1999049869A1 (ja)
ZA (1) ZA997821B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003201D0 (en) * 2000-02-11 2000-04-05 Pharmacia & Upjohn Spa Method to potentiate the therapeutic efficacy of taxane and derivatives thereof
US6436913B1 (en) * 2000-07-25 2002-08-20 Pharmacia & Upjohn Company Use of estramustine phosphate in the treatment of bone metastasis
RU2471511C1 (ru) * 2011-05-04 2013-01-10 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "РНИОИ" Минздравсоцразвития России) Способ лечения метастазов в печень рака толстой кишки

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4584136A (en) * 1984-06-20 1986-04-22 Japan Atomic Energy Research Institute Process for preparing Estracyt compounds having a carcinostatic bound thereto
US5728687A (en) * 1992-11-10 1998-03-17 Rhone-Poulenc Rorer, S.A. Antitumour compositions containing taxane derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
DK0706373T3 (da) * 1992-03-23 2000-09-18 Univ Georgetown Liposomindkapslet taxol og en fremgangsmåde til anvendelse heraf

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4584136A (en) * 1984-06-20 1986-04-22 Japan Atomic Energy Research Institute Process for preparing Estracyt compounds having a carcinostatic bound thereto
US5728687A (en) * 1992-11-10 1998-03-17 Rhone-Poulenc Rorer, S.A. Antitumour compositions containing taxane derivatives

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GARCIA A A ET AL: "PHASE I AND PHARMACOLOGIC STUDY OF ESTRAMUSTINE PHOSPHATE AND SHORTINFUSIONS OF PACLITAXEL IN WOMEN WITH SOLID TUMORS", JOURNAL OF CLINICAL ONCOLOGY, PHILADELPHIA, PA, US, vol. 16, no. 9, September 1998 (1998-09-01), pages 2959 - 2963, XP001000703 *
GUNNARSSON ET AL: "Pharmacokenetics of estramustine phosphate in prostatic cancer patients", EUR.J.PHARMACOL, vol. 26, 1984, pages 113 - 119 *
HUDES G R ET AL: "PACLITAXEL PLUS ESTRAMUSTINE IN METASTATIC HORMONE-REFRACTORY PROSTATE CANCER", SEMINARS IN ONCOLOGY, BETHESDA, MD, US, vol. 22, no. 5, SUPPL 12, October 1995 (1995-10-01), pages 41 - 45, XP001000716 *
NAGEL ET AL: "Treatment of advanced carcinoma of the prostrate with estramustine phopshate", BR.J.UROL., vol. 49, 1977, pages 73 - 79 *
See also references of WO9949869A1 *

Also Published As

Publication number Publication date
HUP0200547A2 (hu) 2002-07-29
AU3353399A (en) 1999-10-18
PL342969A1 (en) 2001-07-16
CN1636598A (zh) 2005-07-13
CN1273530A (zh) 2000-11-15
BR9906425A (pt) 2000-07-11
AU750010B2 (en) 2002-07-11
EA004647B1 (ru) 2004-06-24
CA2295049A1 (en) 1999-10-07
NO20002343D0 (no) 2000-05-04
ID24504A (id) 2000-07-20
EP1003521A1 (en) 2000-05-31
IL133612A0 (en) 2001-04-30
EA199901081A1 (ru) 2000-12-25
HUP0200547A3 (en) 2003-07-28
JP2001508810A (ja) 2001-07-03
WO1999049869A1 (en) 1999-10-07
NO20002343L (no) 2000-05-04
ZA997821B (en) 2000-08-01
KR20010021656A (ko) 2001-03-15
NZ501987A (en) 2002-10-25

Similar Documents

Publication Publication Date Title
GB2342583B (en) Cranial bolt
IL142865A0 (en) Methods and compositions for the prevention of tolerance to medications
GB2337877B (en) Connector fitting structure
GB9818052D0 (en) Fastening arrangements
TW383931U (en) Structure improvement for fastener of connector
GB9824341D0 (en) Securing spaced elements to one other
PL342969A1 (en) Methods to potentiate intravenous estramustine phosphate
HUP0102412A3 (en) 2"-deoxy hygromycin derivatives
GB9816740D0 (en) Improvements to vehicle side-curtains
GB2321389B (en) Improvements to shelving
EP1109566A4 (en) GCP
EP1073669A4 (en) GCP
GB9904033D0 (en) Improvements to bowsers
TW426238U (en) Fastening structure for connector
GB9819088D0 (en) Improvemnts relating to anchorage assemblies
GB9805721D0 (en) Linked power lines
GB9812886D0 (en) Further improvements relating to cell-free systems
GB9803012D0 (en) Omnisphere special effects system
GB9904078D0 (en) Technical accelerator
GB9807899D0 (en) Improvemnets relating to animation
GB9826469D0 (en) Snapfast bolt
TW375331U (en) Structure of the connector
GB9813674D0 (en) Anti-cancer agent
GB9807773D0 (en) Anti-cancer agent
GB9807986D0 (en) The never out of date system

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000120

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: SI PAYMENT 20000120

A4 Supplementary search report drawn up and despatched

Effective date: 20030606

17Q First examination report despatched

Effective date: 20031119

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PHARMACIA & UPJOHN COMPANY LLC

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050924